CEA Grants Roche License to Patent that Covers a Process for Synthesis of dsRNA

News

Published: April 13, 2006

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "CEA Grants Roche License to Patent that Covers a Process for Synthesis of dsRNA"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Listen with

Speechify

0:00

Thank you. Listen to this article using the player above. ✖

Read time:

The CEA has announced that its life science division has granted Roche Diagnostics GmbH, (Mannheim, Germany) a non-exclusive license under the patent family EP10618966.

This license concerns some RNAi products that Roche Diagnostics GmbH supplies to its customers in the research reagent field.

This patent family, owned solely by the CEA, covers a process for an enzymatic synthesis of double-stranded RNA based on the transcription of a double-stranded DNA template.

Double-stranded RNA triggers different types of gene silencing named RNA silencing or RNA interference. The application of RNA interference in mammals has the potential to allow therapeutic gene silencing.

Genomics Research

Genomics Research

CEA Grants Roche License to Patent that Covers a Process for Synthesis of dsRNA